| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029169473 |
| P356 | DOI | 10.1134/S0006297916110134 |
| P932 | PMC publication ID | 5471837 |
| P698 | PubMed publication ID | 27914461 |
| P2093 | author name string | E K Koltsova | |
| A R Fatkhullina | |||
| I O Peshkova | |||
| P2860 | cites work | Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice | Q62658826 |
| Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice | Q62735590 | ||
| Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice | Q62735862 | ||
| Interleukin-10 blocks atherosclerotic events in vitro and in vivo | Q64381132 | ||
| IL-4 induces apoptosis of endothelial cells through the caspase-3-dependent pathway | Q73230890 | ||
| Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions | Q73893504 | ||
| Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice | Q74171931 | ||
| The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice | Q74598506 | ||
| Transforming growth factor-beta: a local or systemic mediator of plaque stability? | Q77148663 | ||
| Cytokines in the pathogenesis of atherosclerosis | Q78321128 | ||
| An inflammatory pathway of IFN-gamma production in coronary atherosclerosis | Q79445166 | ||
| IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice | Q79734270 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α | Q83160032 | ||
| The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice | Q84738724 | ||
| Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
| IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 | ||
| TNF biology, pathogenic mechanisms and emerging therapeutic strategies | Q26776492 | ||
| Neutrophils in atherosclerosis: from mice to man | Q26852048 | ||
| Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway. | Q27312371 | ||
| IL-17 and Th17 Cells | Q27860566 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| New Markers of Inflammation and Endothelial Cell Activation | Q28211342 | ||
| The IL-20 subfamily of cytokines--from host defence to tissue homeostasis | Q28252101 | ||
| The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 | ||
| IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 | ||
| CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation | Q28506984 | ||
| The composition and signaling of the IL-35 receptor are unconventional | Q28589897 | ||
| IL-33 reduces the development of atherosclerosis | Q28594104 | ||
| Immunological and inflammatory functions of the interleukin-1 family | Q29619669 | ||
| Recent insights into the cellular biology of atherosclerosis | Q30300194 | ||
| Cardiovascular disease risk factors: epidemiology and risk assessment. | Q30384873 | ||
| Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis | Q30425368 | ||
| Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice | Q30432644 | ||
| Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent | Q30440410 | ||
| Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? | Q33215522 | ||
| The role of interleukin-18 in the metabolic syndrome | Q33804391 | ||
| IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation. | Q33826622 | ||
| Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size | Q34028839 | ||
| The immunobiology of interleukin-27. | Q34471174 | ||
| Interleukin-4 and interleukin-13: their similarities and discrepancies | Q34488885 | ||
| Cytokines in atherosclerosis: pathogenic and regulatory pathways | Q34511711 | ||
| Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. | Q34520320 | ||
| Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility | Q34782136 | ||
| Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice | Q35050827 | ||
| The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice | Q35792034 | ||
| The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment | Q35915712 | ||
| The role of natural antibodies in atherogenesis | Q36129564 | ||
| Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis | Q36202794 | ||
| Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice | Q36202916 | ||
| The varying faces of IL-6: From cardiac protection to cardiac failure. | Q36368339 | ||
| Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype | Q36379539 | ||
| IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis | Q36849075 | ||
| Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia | Q36855687 | ||
| Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis | Q36862166 | ||
| Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement | Q37016372 | ||
| Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice | Q37114519 | ||
| Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma | Q37239764 | ||
| Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques | Q37257235 | ||
| Induction, function and regulation of IL-17-producing T cells | Q37311131 | ||
| Immune and inflammatory mechanisms of atherosclerosis (*) | Q37325024 | ||
| The role of adaptive T cell immunity in atherosclerosis | Q37339539 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| Inflammation and plaque vulnerability | Q37370224 | ||
| Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis | Q37377439 | ||
| Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice | Q37729656 | ||
| Interleukin-17: friend or foe in atherosclerosis? | Q37777607 | ||
| Regulation and functions of the IL-10 family of cytokines in inflammation and disease | Q37821924 | ||
| Recent advances on the role of cytokines in atherosclerosis | Q37867358 | ||
| Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily | Q37873404 | ||
| Plasticity and cross-talk of interleukin 6-type cytokines | Q38010926 | ||
| IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. | Q38058509 | ||
| Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms | Q38134246 | ||
| Monocyte recruitment and macrophage proliferation in atherosclerosis. | Q38187937 | ||
| IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles | Q38252438 | ||
| Development, differentiation, and diversity of innate lymphoid cells | Q38252608 | ||
| IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. | Q38539817 | ||
| Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions | Q38673368 | ||
| IL-33 reduces macrophage foam cell formation. | Q39693915 | ||
| IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses | Q39797207 | ||
| CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions | Q40584986 | ||
| Interleukin-6 exacerbates early atherosclerosis in mice | Q40793841 | ||
| Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth | Q40880886 | ||
| Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity | Q41489951 | ||
| Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis | Q41504728 | ||
| IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. | Q41737320 | ||
| Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma | Q42162162 | ||
| Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice | Q42757050 | ||
| A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice | Q42856694 | ||
| Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice | Q43455128 | ||
| T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia | Q43624009 | ||
| Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. | Q43631840 | ||
| Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. | Q43794492 | ||
| IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice | Q44090158 | ||
| Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice | Q44302731 | ||
| Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. | Q45158735 | ||
| Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes | Q46323162 | ||
| Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis | Q46323475 | ||
| Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice | Q46432117 | ||
| Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice | Q46507912 | ||
| Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha | Q46773827 | ||
| Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice | Q47835280 | ||
| Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors | Q48425484 | ||
| Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. | Q53359008 | ||
| IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice. | Q53369976 | ||
| Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. | Q53553905 | ||
| IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-γ and CXCL16 Expression Independently of T Cells | Q57987937 | ||
| Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability | Q58150063 | ||
| Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability | Q58150092 | ||
| Protective Role of Interleukin-10 in Atherosclerosis | Q58150380 | ||
| P433 | issue | 11 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1358-1370 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Biochemistry | Q4086944 |
| P1476 | title | The Role of Cytokines in the Development of Atherosclerosis | |
| P478 | volume | 81 |
| Q57792124 | 5,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone attenuates LPS-induced inflammation and ROS production in EA.hy926 cells via HMBOX1 induction |
| Q90221587 | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease |
| Q50953812 | Anti-Inflammatory Activities and Liver Protection of Alisol F and 25-Anhydroalisol F through the Inhibition of MAPK, STAT3, and NF-κB Activation In Vitro and In Vivo. |
| Q48173847 | Cis-bifenthrin induces immunotoxicity in adolescent male C57BL/6 mice |
| Q90694588 | Corylin Inhibits Vascular Cell Inflammation, Proliferation and Migration and Reduces Atherosclerosis in ApoE-Deficient Mice |
| Q112744936 | Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice |
| Q55642833 | Effects of arterial blood on the venous blood vessel wall and differences in percentages of lymphocytes and neutrophils between arterial and venous blood. |
| Q98892235 | Involvement of the toll-like receptors-2/nuclear factor-kappa B signaling pathway in atherosclerosis induced by high-fat diet and zymosan A in C57BL/6 mice |
| Q93164892 | Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis |
| Q47930108 | MicroRNA-21 suppresses ox-LDL-induced human aortic endothelial cells injuries in atherosclerosis through enhancement of autophagic flux: Involvement in promotion of lysosomal function |
| Q92135292 | Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood |
| Q92443249 | Potential Beneficial Effects of Vitamin D in Coronary Artery Disease |
| Q46317233 | Secreted frizzled-related protein 5 protects against oxidative stress-induced apoptosis in human aortic endothelial cells via downregulation of Bax. |
| Q90291193 | Stability and inhibitory function of Treg cells under inflammatory conditions in vitro |
| Q53139734 | Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation. |
| Q90733135 | The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease |
| Q98291995 | The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs |
| Q40106543 | The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice |
| Q41459873 | The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. |
| Q42361233 | Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis. |
Search more.